Involvement of Endogenous Tumor Necrosis Factor Alpha and Transforming Growth Factor Beta During Induction of Collagen Type II Arthritis in Mice

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 Aug 15

PMID 1502148

Citations 99

Authors

G J Thorbecke

R Shah

C H Leu

A P Kuruvilla

A M Hardison

M A Palladino

Affiliations

Soon will be listed here.

Abstract

Both tumor necrosis factor alpha (TNF-alpha) and transforming growth factor beta (TGF-beta) are found in synovial fluid from arthritic joints of humans and of rodents with experimental arthritis. The role of endogenously produced TGF-beta and TNF in the pathogenesis of collagen type II-induced arthritis (CIA) in DBA/1 mice was examined by determining the effect of neutralizing monoclonal antibodies to these factors on the course of the disease. Endogenously produced as well as systemically administered TGF-beta 1 and TNF-alpha had opposite effects, since TGF-beta 1 and anti-TNF protected against CIA, whereas anti-TGF-beta and TNF-alpha increased CIA incidence and/or severity. Intraperitoneally injected TGF-beta 1 at a dose of 2 micrograms per day for 14 days significantly ameliorated arthritis, even when started at the time of arthritis development, although it did not reverse established disease. The resistance to CIA induction caused by a prior intravenous injection of collagen type II was not significantly influenced by the simultaneous injection of TGF-beta 1, TNF-alpha, or interleukin 1 alpha. It is concluded that the endogenous production of TNF and TGF-beta is important in determining the course of CIA.

Citing Articles

Local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis.

Aarts J, van Caam A, Chen X, Marijnissen R, Helsen M, Walgreen B Sci Rep. 2022; 12(1):3182.

PMID: 35210510 PMC: 8873460. DOI: 10.1038/s41598-022-07075-w.

Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.

Czaja A Dig Dis Sci. 2021; 67(4):1163-1186.

PMID: 33835375 DOI: 10.1007/s10620-021-06968-6.

Hydrogel is Superior to Fibrin Gel as Matrix of Stem Cells in Alleviating Antigen-Induced Arthritis.

Liu H, Ding J, Li C, Wang C, Wang Y, Wang J Polymers (Basel). 2019; 8(5).

PMID: 30979276 PMC: 6431989. DOI: 10.3390/polym8050182.

Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis.

Barrachina L, Remacha A, Romero A, Vitoria A, Albareda J, Prades M BMC Vet Res. 2018; 14(1):241.

PMID: 30119668 PMC: 6098603. DOI: 10.1186/s12917-018-1556-3.

TNF inhibits catecholamine production from induced sympathetic neuron-like cells in rheumatoid arthritis and osteoarthritis in vitro.

Herrmann M, Anders S, Straub R, Jenei-Lanzl Z Sci Rep. 2018; 8(1):9645.

PMID: 29941879 PMC: 6018168. DOI: 10.1038/s41598-018-27927-8.

References

Arend W, Welgus H, Thompson R, Eisenberg S . Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest. 1990; 85(5):1694-7. PMC: 296623. DOI: 10.1172/JCI114622. View

Arita C, Kaibara N, Hotokebuchi T, Takagishi K, Arai K . Effect of cyclophosphamide and its analogs on collagen arthritis in rats. Clin Immunol Immunopathol. 1987; 43(3):354-61. DOI: 10.1016/0090-1229(87)90145-0. View

Lotz M, Kekow J, Carson D . Transforming growth factor-beta and cellular immune responses in synovial fluids. J Immunol. 1990; 144(11):4189-94. View

Allen J, Manthey C, Hand A, Ohura K, Ellingsworth L, Wahl S . Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med. 1990; 171(1):231-47. PMC: 2187661. DOI: 10.1084/jem.171.1.231. View

Weigle W, Scheuer W, Hobbs M, MORGAN E, Parks D . Modulation of the induction and circumvention of immunological tolerance to human gamma-globulin by interleukin 1. J Immunol. 1987; 138(7):2069-74. View

Sheehan K, Ruddle N, Schreiber R . Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol. 1989; 142(11):3884-93. View

Straub C, Zubler R . Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta. J Immunol. 1989; 142(1):87-93. View

Kehrl J, Taylor A, Delsing G, Roberts A, Sporn M, Fauci A . Further studies of the role of transforming growth factor-beta in human B cell function. J Immunol. 1989; 143(6):1868-74. View

Lafyatis R, Thompson N, Remmers E, Flanders K, Roche N, Kim S . Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol. 1989; 143(4):1142-8. View

10.

Belsito D, Epstein S, SCHULTZ J, Baer R, Thorbecke G . Enhancement by various cytokines or 2-beta-mercaptoethanol of Ia antigen expression on Langerhans cells in skin from normal aged and young mice. Effect of cyclosporine A. J Immunol. 1989; 143(5):1530-6. View

11.

Kehrl J, Wakefield L, Roberts A, Jakowlew S, Alvarez-Mon M, Derynck R . Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986; 163(5):1037-50. PMC: 2188095. DOI: 10.1084/jem.163.5.1037. View

12.

Shalaby M, Ammann A . Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta. Cell Immunol. 1988; 112(2):343-50. DOI: 10.1016/0008-8749(88)90303-6. View

13.

Czarniecki C, Chiu H, Wong G, McCabe S, Palladino M . Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol. 1988; 140(12):4217-23. View

14.

Banerjee S, Wei B, Hillman K, Luthra H, David C . Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J Immunol. 1988; 141(4):1150-4. View

15.

Kramer S, Carver M . Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol Methods. 1986; 93(2):201-6. DOI: 10.1016/0022-1759(86)90189-4. View

16.

Pennica D, Hayflick J, Bringman T, Palladino M, Goeddel D . Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci U S A. 1985; 82(18):6060-4. PMC: 390699. DOI: 10.1073/pnas.82.18.6060. View

17.

Louis J, Chiller J, Weigle W . The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. Cellular parameters. J Exp Med. 1973; 138(6):1481-95. PMC: 2139451. DOI: 10.1084/jem.138.6.1481. View

18.

Cremer M, Hernandez A, Townes A, Stuart J, Kang A . Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol. 1983; 131(6):2995-3000. View

19.

Trentham D, Townes A, Kang A . Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977; 146(3):857-68. PMC: 2180804. DOI: 10.1084/jem.146.3.857. View

20.

Karpus W, Swanborg R . CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J Immunol. 1991; 146(4):1163-8. View